E989-0215 Screening compound: 4-{2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide

E989-0215 Screening compound: 4-{2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide
E989-0215 Screening compound: 4-{2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E989-0215
4-{2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E989-0215

Molecular Formula

C20H26N4O2S (C20 H26 N4 O2 S)

Compound Name

4-{2-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide

IUPAC name

4-{2-methyl-4H5H6H7H-pyrazolo[15-a]pyrimidin-4-yl}-N-{2-[4-(methylsulfanyl)phenyl]ethyl}-4-oxobutanamide

SMILES

Cc1nn(CCCN2C(CCC(NCCc(cc3)ccc3SC)=O)=O)c2c1

InChI

InChI=1S/C20H26N4O2S/c1-15-14-19-23(12-3-13-24(19)22-15)20(26)9-8-18(25)21-11-10-16-4-6-17(27-2)7-5-16/h4-7,14H,3,8-13H2,1-2H3,(H,21,25)

InChI Key

BOQQXQICQZZRQP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14936326

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

386.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.637

Distribution Coefficient, logD

1.637

Water Solubility, LogSw

-2.39

Polar Surface Area

51.817

Acid Dissociation Constant (pKa)

14.31

Base Dissociation Constant (pKb)

1.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

E989-0215 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with E989-0215 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E989-0215?
Check Price and Availability of E989-0215, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E989-0215 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E989-0215
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E989-0215
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E989-0215 available by request